Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| Market is closed on Tue. Jan. 30, 2024 | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 0% (three month average) | | RSI | | | Latest Price | $(0%) | | Stocks Behave Similarly | Similar Stock List | | Market Behavior | Rotation from growth to value for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability)
(0%) (0%) (0%) (0%) (0%) | | Factors Impacting FOLD price | FOLD will advance at least -0% in a week (0% probabilities).
(0%) (0%) (0%) (0%) (0%) | | | | | | | | Relative Volatility | | | | | | Market Trend Strength | 0% (StdDev 0%) | | Hourly BBV | 0 () | | Intraday Trend | NAN% | | | | | |
|
Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |